Archives for July 14, 2005

← 2005

New technique enhances ADME/Tox predictions

A new in silico technique for generating enhanced predictions for ADME/Tox research could have new implications in developing novel drug techniques in combating drug-resistant infectious diseases and cancer.

Life Therapeutics acquires Pyramid Biological Corp

Life Therapeutics has announced the acquisition of Pyramid Biological Corporation in a deal that increases Life Therapeutics presence in the source plasma sector - a market that has nearly doubled, from $125 million (€103 million) to $230 million,...

Pharma shift determines venture capital landscape

According to new data, venture capital funding is on a downswing with a demand for acquisitions shifting in the pharmaceutical sector. The news could signal a trend towards the acquisition of compounds, rights, licenses and product lines, rather than...

T-cell control discovery boosts new drug research

Scientists have taken a major step forward in autoimmune disease research after the process of T-cell trafficking through the blood and lymph nodes to fight infection was discovered. Controlling this process with drugs offers "enormous potential"...

DSM takes control of biologics unit

DSM Pharmaceutical Products has taken full control of its biologics manufacturing unit after buying out its Canadian joint venture partner.

American Pacific buys pharma ingredients firm

American Pacific Corp has agreed to acquire the assets of Aerojet Fine Chemicals for $119 million (€98m), in a deal which APC said would give it access to 'fast-growing pharmaceutical markets'.

Guidance from EMEA on plastic packaging

The European Medicines Agency has published updated guidelines on the use of plastic packaging in pharmaceuticals, in a bid to help packagers select the best and safest materials for their products.